Clinical Trial Update: Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab [Phase 4]

View source ↗

Summary

Phase 4 trial exploring musculoskeletal ultrasound to predict early dose titration of tocilizumab in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2018-11-29